STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to jumpstart immune system against early blood cancer
Disease control OngoingThis study tests whether the drug lenalidomide, combined with a vaccine, can help the immune system fight early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients with high-risk genetic features. About 49 participants will receive the treatme…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Major CLL study tests best drug combo for seniors
Disease control OngoingThis study is for people aged 65 and older with untreated chronic lymphocytic leukemia (CLL). It compares three treatment plans: two different drug combinations (bendamustine plus rituximab, or ibrutinib plus rituximab) versus ibrutinib alone. The goal is to see which approach wo…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Matched conditions: STAGE II CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC